Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FR9TP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,653
Award facts
- Contract value 100% obligated
- $69,653.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vraylar 3 mg capsules (30-count units) under a firm fixed-price arrangement with a ceiling value of $69,653.48. This non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order is scheduled for completion by September 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania.
Vraylar, an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, is part of the comprehensive pharmaceutical support AmerisourceBergen provides to military healthcare systems and other federal agencies through its DLA contracts. As a major pharmaceutical distributor, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order reflects the company's continued role as a critical vendor within the DLA's pharmaceutical supply chain, fulfilling medical procurement needs for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FR9TP?
SPE2DB25FR9TP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FR9TP worth?
The government has obligated $69,653 on SPE2DB25FR9TP.
Is contract SPE2DB25FR9TP an order under another contract?
Yes. SPE2DB25FR9TP is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9TP competed?
The extent of competition for SPE2DB25FR9TP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award